After a period of horror and human loss due to the ongoing pandemic issue, now all the countries are gearing up to take the necessary measures and we might soon have a huge success on the vaccine front.
The USA Might Soon Begin Their Vaccine Run While New Development Has Emerged In The Sputnik V Vaccine.
The USA is all set to start its vaccine administration very soon and it is expected to be sometime around this coming few days! The USA suffered a huge loss of human life as the number of cases and death have taken a toll on the country.
📸: The first shipment from our Kalamazoo plant. @UPS @FedEx
.
.
The Pfizer-BioNTech #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16+. See conditions of use: https://t.co/OS1tgYopUj pic.twitter.com/yogti0Ahcq— Pfizer Inc. (@pfizer) December 13, 2020
Along with Pfizer vaccine development, there has been new growth on another vaccine as the Developers of the Sputnik V coronavirus vaccine from Russia has stated that it will be effective for up to two years. Pfizer has been keeping people updates through their social media posts and it seems like the vaccines are out for use and we will soon know how affective it is in the long run after it is out for use.
NEWS: The Pfizer-@BioNTech_Group #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16 & older. See conditions of use: https://t.co/RbC0OwSEEi pic.twitter.com/9b2BYPFk9Z
— Pfizer Inc. (@pfizer) December 12, 2020
The Sputnik V Vaccine Is Still On The Trial Run!
While the Sputnik V vaccine still in the trial stage, medical authorities are claiming that the vaccine is going to protect for almost two whole years. This has been further explained by Alexander Gintsburg, who is the head of the vaccine’s developer, Gamaleya National Research Center for Epidemiology and Microbiology.
BREAKING: The #SputnikV vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials. https://t.co/E9j1wk2YZT #covidvaccine #coronavirus #COVID19
— Sputnik V (@sputnikvaccine) December 14, 2020
However, in the spirit of fighting this ongoing pandemic, US FDA has recently granted emergency use authorization to the Pfizer-BioNTech COVID-19 vaccine on Saturday. With this approval, the first doses of the vaccine distribution are reportedly going to begin on Monday.